Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Refractory Juvenile Dermatomyositis
NCT02594735Phase 4Completed
- Sponsor
- George Washington University
- Start
- Nov 2015
- Primary completion
- Jul 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in juvenile dermatomyositis (JDM), sponsored by George Washington University. Started Nov 2015; status: completed.
02
Drugs
abatacept
03
Conditions
juvenile dermatomyositis (JDM)
Beyond the preview
Go deeper on NCT02594735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594735.